AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
2
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
3
Check Point raises $1.75 billion, potentially eyeing AI expansion
4
Nice puts Actimize up for sale at a $1.5-2 billion price tag
5
Hapag-Lloyd eyes ZIM acquisition, workers push back
More news

Investing

12 stories about Investing
default image

A bubble in the making? The Tel Aviv Stock Exchange is experiencing a record year

19.01.21|Yaniv Rahimi
The public may remember 2020 as a year of unemployment and lockdowns, but investors have put pedal to the metal with 25 companies going public, earning an average return of 34%
רקטת צמיחה

Unicorn School Lessons 7 and 8: Equity trumps salaries and the path to $100 billion companies

25.12.20|Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leaped beyond $2 billion offer insights and tips for building unicorns
השקעה חיסכון כסף קופות גמל קרנות השתלמות קרן השתלמות

Unicorn School Lesson 6: Making an exit: when you fly too fast, the plane shakes

24.12.20|Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leaped beyond $2 billion offer insights and tips for building unicorns
מוסף שבועי 17.12.20 מימין עמית בן דב חן עמית ו אלון חורי

Unicorn School Lesson 5: Don’t turn down money that hits you in the face

23.12.20|Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leaped beyond $2 billion offer insights and tips for building unicorns
השקעה חיסכון כסף קופות גמל קרנות השתלמות קרן השתלמות

Unicorn School Lessons 3 and 4: Stick to a business model and don't indulge in frivolous luxuries

22.12.20|Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leaped beyond $2 billion offer insights and tips for building unicorns
ג'ון קורנגולד בלאקסטון SohnX

“We haven't seen this type of divorce from reality since the dot-com boom”

21.12.20|CTech
Senior Managing Director and Global Head of Blackstone's Growth Equity Business, Jon Korngold, doesn’t believe we are in a stock market bubble but says there is definitely a relaxing of some of the discipline we have come to see in the public markets in recent years
מוסף שבועי 17.12.20 מימין עמית בן דב חן עמית ו אלון חורי

Unicorn School Lesson 1: $100 billion egos and the mentality of a watermelon

20.12.20|Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leapt beyond $2 billion offer insights and tips for building unicorns
ענת גואטה זירת ההשקעות חדש

“Israeli high tech has found a home at the Tel Aviv Stock Exchange,” says Chairwoman of the Israel Securities Authority

16.12.20|Hezi Sternlicht
“Capital markets are enjoying a renaissance period,” Anat Guetta said during Calcalist’s investment conference. “High tech has returned to Israel. It’s no longer aiming to raise money in foreign markets”
Participant in J-Vanture's panel on investing in Uniorns

How to create a stable of unicorns: J-Ventures panel debates investments in the biggest tech companies

16.12.20|CTech
Michael Rolnick, Merav Weinryb, Jake Sein, and Brett Rokhind discuss their investment strategies at J-Ventures’ annual Investors Conference
חוות השרתים התת קרקעית ב הר חוצבים

How will engineering look in the future and what is going on under Jerusalem's hills?

05.08.20|CTech
CTech Daily Roundup: Lawsuit claims Harman dodged millions of dollars in payments after 2016 TowerSec acquisition
Sherrie Wang Managing Partner Shengjing Peakview Capital

$100 million investment in Israel is just the beginning, says Shengjing Peakview Capital exec

16.07.20|Allon Sinai
Sherrie Wang, Managing Partner at one of China's largest global fund of funds, is optimistic regarding China-Israel economic relations
מנכ"ל טבע החדש קור שולץ 2

Activist Investor Jana Partners Takes Stake in Teva, Report Says

23.01.18|Lilach Baumer
The firm has taken a position in the troubled drugmaker during the fourth quarter of 2017, believing CEO Kåre Schultz's cost-cutting measures could turn the company around, according to a Bloomberg report
Previous Articles